Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 2000
Primary Completion Date
November 30, 2004
Conditions
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Interventions
DRUG
oxaliplatin
DRUG
topotecan hydrochloride
Trial Locations (1)
10016
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
NYU Langone Health
OTHER
NCT00006391 - Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter